Nationwide Laboratories Recalls Salsalate Tablets Due to Manufacturing Deviations
Nationwide Laboratories is recalling Salsalate Tablets, 750 mg, because they were manufactured under practices that may result in assay or content uniformity failures.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves potential assay or content uniformity failures without reported illnesses or injuries, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Nationwide Laboratories, LLC is recalling Salsalate Tablets, USP, 750 mg. The affected product is packaged in 100, 500, and 1000 count bottles and is available by prescription only. The recall involves 2,514,500 tablets distributed nationwide in the USA and Puerto Rico.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the tablets were manufactured under practices which may result in assay or content uniformity failures. This means the amount of active ingredient in the tablets may not be consistent or accurate.
Patients who have been prescribed Salsalate Tablets, USP, 750 mg, should contact their healthcare provider or pharmacist for guidance on how to proceed. The specific lot numbers and expiration dates are listed in the structured product information provided by the FDA.
The recalled product
- Product
- Salsalate Tablets, USP, 750 mg, packaged in a) 100 count bottles (NDC 42937-704-10); b) 500 count bottles (NDC 42937-704-18); and c) 1000 count bottles (NDC 42937-704-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.
- Manufacturer
- Nationwide Laboratories, LLC
- Category
- Drug — Prescription Medication
- Affected units
- 2,514,500
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot #: a) 28141502
- 28141503
- 28141504
- 28141505
- 28141506
- Exp 03/17
- 28141507
- Exp 09/17
- 28141508
- 28141510
- 28141511
- Exp 10/17
- b) 28141502
- c) 28141501
- 28141502
Distribution
Part of a larger recall action
This product is one of 4 recalled by Nationwide Laboratories, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Nationwide Laboratories, LLC
See all →- Moderate
- ModerateNationwide Laboratories Recalls Phenazopyridine Hydrochloride Tablets Due to CGMP Deviations
FDA (Drugs) · 2016-12-07
- ModerateNationwide Laboratories Recalls Salsalate Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2016-12-07
Same hazard · content uniformity
See all →- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- HighOral contraceptive tablets recalled after failing content uniformity specifications
FDA (Drugs) · 2025-10-15
- HighCefixime Oral Suspension Recalled for Failed Content Uniformity Specifications
FDA (Drugs) · 2024-06-26
- SevereFDA Recalls Phenytoin Oral Suspension Due to Content Uniformity Failure
FDA (Drugs) · 2023-12-27
- ModerateDofetilide Capsules Recalled Due to Out-of-Specification Content Uniformity
FDA (Drugs) · 2023-08-16